Importantly, the stimulatory effects of miR-500 on gastric cancer cell proliferation and survival were markedly reduced upon NF-κB inhibition by transfection of IκBα-mut or treatment with a NF-κB inhibitor (Figure 4F and 4G). Here, NFKBIA is linked to gastric cancer.